Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H44O2 |
| Molecular Weight | 400.6371 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@@]4(C)CC[C@H](O)CC4=CC3=O
InChI
InChIKey=YIKKMWSQVKJCOP-ABXCMAEBSA-N
InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-23,25,28H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,25+,26+,27-/m1/s1
| Molecular Formula | C27H44O2 |
| Molecular Weight | 400.6371 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
7-Oxocholesterol (7-Ketocholesterol) is a major oxidation product of cholesterol (oxysterol) found in human atherosclerotic plaque and is more atherogenic than cholesterol in some animal studies. Oxysterols (oxygenated forms of cholesterol) are present at low levels in the circulation and accumulate is plasma and tissues in some pathologies. In atherosclerotic lesions, 7-oxygenated oxysterols, predominantly 7-ketocholesterol, accumulate and have been implicated in the pathology of the disease. There is some in vivo and in vitro evidence that sterol 27-hydroxylase acts on 7-ketocholesterol to initiate its degradation to more polar, water-soluble products. Recent studies indicate an alternative mechanism, in which 7-ketocholesterol is reduced to 7 beta-hydroxycholesterol by 11 beta-hydroxysteroid dehydrogenase type 1. 7-Ketocholesterol can inhibit cholesterol 7 alpha-hydroxylase, the rate-limiting step in bile acid biosynthesis, as well as strongly inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. It has even been suggested that 7-ketocholesterol is formed enzymically as an endogenous regulator of cholesterol biosynthesis. However, when tested as a pharmacological cholesterol-lowering agent, inhibition of HMG-CoA reductase was rapidly overcome and the 7-ketocholesterol metabolised. In vitro, 7-ketocholesterol has wide-ranging and potent effects, most of which have the potential to contribute to atherosclerosis. For example, 7-ketocholesterol can be cytotoxic and can induce apoptosis in vascular cells. These effects, either individually or more likely, in combination, all implicate 7-ketocholesterol in the initiation and development of atherosclerosis, but further work is needed to establish whether or not its role is a direct causal one. 7-Ketocholesterol is the second most abundant oxysterol found in human atherosclerotic plaque, after the enzymically formed 27-hydroxycholesterol (cholest-5-ene-3beta,27-diol). 7-Ketocholesterol differs from cholesterol by a ketone functional group present at the 7-position. It is produced from cholesterol via the epimeric cholesterol 7-hydroperoxides (cholest-5-ene-3beta-ol-7-hydroperoxide) which decompose to the epimeric 7-hydroxycholesterols (cholest-5-ene-3beta,7-diol) and 7-ketocholesterol. 7-Ketocholesterol is a major dietary oxysterol. It has also been widely suggested that 7-ketocholesterol present in atherosclerotic tissue may be derived from the diet. Certainly, 7-ketocholesterol is a major oxysterol found in cholesterol-rich processed foodstuffs. Dietary 7-ketocholesterol is rapidly metabolised by the liver to 7beta-hydroxycholesterol (cholest-5-ene-3beta,7beta-diol), unusual bile acids and perhaps even cholesterol itself. Its conversion to 7beta-hydroxycholesterol is well documented.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P22680 Gene ID: 1581.0 Gene Symbol: CYP7A1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/10224662 |
|||
Target ID: CHEMBL402 |
|||
Target ID: CHEMBL3201 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22304296 |
7.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. | 2004-08 |
|
| Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase. | 2004-07-23 |
|
| Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. | 2004-06-01 |
|
| The leaf extract of Ginkgo Biloba L. suppresses oxidized LDL-stimulated fibronectin production through an antioxidant action in rat mesangial cells. | 2004-06 |
|
| Comparison of cholesterol oxidation product preparation methods for subsequent gas chromatographic analysis. | 2004-05-29 |
|
| Analysis of cholesterol oxidation products in biological samples. | 2004-05-29 |
|
| Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. | 2004-04-30 |
|
| Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. | 2004-04 |
|
| Oxysterols regulate expression of the steroidogenic acute regulatory protein. | 2004-04 |
|
| Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. | 2004-04 |
|
| Trojan horse-like behavior of a biologically representative mixture of oxysterols. | 2004-03-31 |
|
| Mechanisms of resistance to the cytotoxic effects of oxysterols in human leukemic cells. | 2004-03 |
|
| Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. | 2004-03 |
|
| Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. | 2004-02-03 |
|
| Analysis of the fluorescence of monodansylcadaverine-positive cytoplasmic structures during 7-ketocholesterol-induced cell death. | 2004-02 |
|
| AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. | 2004-01-09 |
|
| Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. | 2004-01 |
|
| Cholesterol oxides mediated changes in cytoskeletal organisation involves Rho GTPases. | 2003-12-10 |
|
| Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. | 2003-10-17 |
|
| Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. | 2003-10-15 |
|
| Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. | 2003-10-15 |
|
| 7-ketocholesterol stimulates differentiation of lens epithelial cells. | 2003-10-06 |
|
| Origin of oxysterols in hepatic bile of patients with biliary infection. | 2003-10 |
|
| Identification and quantification of cholesterol and cholesterol oxidation products in different types of Iberian hams. | 2003-09-10 |
|
| Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. | 2003-09 |
|
| Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury. | 2003-07 |
|
| Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis. | 2003-06-06 |
|
| Consecutive administration of paraquat to rats induces enhanced cholesterol peroxidation and lung injury. | 2003-06 |
|
| Oxysterol-induced toxicity in R28 and ARPE-19 cells. | 2003-06 |
|
| Lysophosphatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor. | 2003-05-01 |
|
| Impairment of the cytotoxic and oxidative activities of 7 beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. | 2003-04-11 |
|
| Presence of phytosterol oxides in crude vegetable oils and their fate during refining. | 2003-04-09 |
|
| Chronology of cellular alterations during 7-ketocholesterol-induced cell death on A7R5 rat smooth muscle cells: analysis by time lapse-video microscopy and conventional fluorescence microscopy. | 2003-04 |
|
| Lipid peroxidation and vitamin E in human coronary atherosclerotic lesions. | 2003-04 |
|
| Cholesterol is superior to 7-ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. | 2003-03-28 |
|
| Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. | 2003-03-01 |
|
| 7-hydroperoxycholesterol and oxysterols as indices of oxidative stress: chronic ethanol feeding and rat skeletal muscle. | 2003-03 |
|
| Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. | 2003-01-15 |
|
| Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. | 2003-01-13 |
|
| Alpha-tocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation. | 2002-12-05 |
|
| Flow cytometry and factor analysis evaluation of confocal image sequences of morphologic and functional changes occurring at the mitochondrial level during 7-ketocholesterol-induced cell death. | 2002-12 |
|
| Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in plasma of patients with essential hypertension. | 2002-11 |
|
| The impairment of endothelium-dependent arterial relaxation by 7-ketocholesterol is associated with an early activation of protein kinase C. | 2002-11 |
|
| Cholesterol oxides, cholesterol, total lipid, and fatty acid composition in turkey meat. | 2002-10-09 |
|
| 7-ketocholesterol in human and adapted milk formulas. | 2002-10 |
|
| Dietary cholesterol-oxidation products accumulate in serum and liver in apolipoprotein E-deficient mice, but do not accelerate atherosclerosis. | 2002-10 |
|
| Protection of superoxide-induced cholesterol oxidation by antioxidants in protic conditions. | 2002-09 |
|
| Oxidized lipoproteins and macrophages. | 2002-04 |
|
| [Concentration of the oxygenated derivates of cholesterol in pregnant women suffering from diabetes type I]. | 2002 |
|
| Oxysterol-induced apoptosis of vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitor, pravastatin. | 2002 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17089016
A group of mice was treated with Oxocholesterol (7-Ketocholesterol) subcutaneously for 1 week (10 mg/kg/day).
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17089016
Human umbilical vein endothelial (HUVEC) cells were treated with 2-16 ug/ml 7-Oxocholesterol (7-Ketocholesterol) as well as vascular rings harvested from BALB/c mouse thoracic aorta with 90 ug/ml 7-Oxocholesterol (7-Ketocholesterol) for 2 h.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:37:01 GMT 2025
by
admin
on
Mon Mar 31 19:37:01 GMT 2025
|
| Record UNII |
O7676FE78M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
92764-0
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
O7676FE78M
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY | |||
|
64294
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY | |||
|
C003001
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY | |||
|
91474
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY | |||
|
566-28-9
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY | |||
|
DTXSID901033744
Created by
admin on Mon Mar 31 19:37:01 GMT 2025 , Edited by admin on Mon Mar 31 19:37:01 GMT 2025
|
PRIMARY |